Glucagon-like peptide-1 does not have acute effects on central or renal hemodynamics in patients with type 2 diabetes without nephropathy
about
Differential effects of glucagon-like peptide-1 receptor agonists on heart rate.Postprandial renal haemodynamic effect of lixisenatide vs once-daily insulin-glulisine in patients with type 2 diabetes on insulin-glargine: An 8-week, randomised, open-label trial.Targeting cardiac natriuretic peptides in the therapy of diabetes and obesity.Glucagon-like peptide-1 elicits vasodilation in adipose tissue and skeletal muscle in healthy men.A sandwich ELISA for measurement of the primary glucagon-like peptide-1 metabolite.Natriuretic peptides in the control of lipid metabolism and insulin sensitivity.
P2860
Glucagon-like peptide-1 does not have acute effects on central or renal hemodynamics in patients with type 2 diabetes without nephropathy
description
scientific article published on 08 March 2016
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в травні 2016
@uk
name
Glucagon-like peptide-1 does n ...... 2 diabetes without nephropathy
@en
Glucagon-like peptide-1 does n ...... 2 diabetes without nephropathy
@nl
type
label
Glucagon-like peptide-1 does n ...... 2 diabetes without nephropathy
@en
Glucagon-like peptide-1 does n ...... 2 diabetes without nephropathy
@nl
prefLabel
Glucagon-like peptide-1 does n ...... 2 diabetes without nephropathy
@en
Glucagon-like peptide-1 does n ...... 2 diabetes without nephropathy
@nl
P2093
P2860
P50
P1476
Glucagon-like peptide-1 does n ...... 2 diabetes without nephropathy
@en
P2093
Erik Frandsen
Lene Simonsen
Meena Asmar
Thomas Jonassen
P2860
P304
P356
10.1152/AJPENDO.00518.2015
P577
2016-03-08T00:00:00Z